Larimar Therapeutics, Inc. (LRMR) - Latest Market Data

Price & Market Data

Price: $3.81

Daily Change: -$0.24 / 6.30%

Daily Range: $3.81 - $4.15

Market Cap: $335,514,336

Daily Volume: 940,642

Performance Metrics

1 Week: 2.62%

1 Month: 19.15%

3 Months: -2.00%

6 Months: 35.64%

1 Year: -39.69%

YTD: 1.29%

Company Details

Employees: 65

Sector: Health technology

Industry: Biotechnology

Country:

Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Selected stocks

Titan Mining Corporation (TII)

Pineapple Financial Inc. (PAPL)

Cellectis S.A. Sponsored ADR (CLLS)